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ABSTRACT 
Several plants have been used in ancient times as medicines to treat, manage and prevent many 
diseases in various traditional settings throughout the world. The effect of administration of hydro-
ethanolic extract of Laportea aestuans (La) leaves at different doses in Wistar rats induced with 
benign prostatic hyperplasia (BPH) was studied using antioxidant parameters, prostate specific 
antigen (PSA), relative prostate weight and phytochemical screening. Thirty (30) animals were 
randomly divided into six (6) groups (A-F) of five (5) animals each. BPH was induced in the 
animals by daily subcutaneous injection of testosterone propionate (TP) (3mg/kg) in olive oil and 
administration of treatments for four (4) weeks were done concurrently. Group A received olive 
oil alone subcutaneously, group B was induced with BPH alone, groups C-E were induced with 
BPH but received different doses of La at 100, 200 and 400mg/kg. Lastly, group F was induced 
with BPH but treated with finasteride (5mg/kg) which serves as the positive control group. 
Phytochemical screening results shows that saponins, flavonoids (0.5010±0.0009mg/ml), alkaloids 
(0.528mg/ml), phenols  (0.6195±0.0015mg/ml), tannins (0.5410±0.0013mg/ml) and steroids 
(1.6230±0.0210 mg/ml) were present in hydro-ethanolic extract of La. The relative prostate weight 
result decreased significantly (p<0.05) in the 400mg/kg La (1.15± 0.14mg) in comparison to the 
BPH group (1.58±0.05mg). PSA level also decreased significantly (p<0.05) in the 400mg/kg La 
(131±1.91pg/ml) when compared to the BPH group (174±4.13pg/ml). Meanwhile, the levels of 
SOD, CAT and GSH increased significantly (p<0.05) at 400mg/kg La (48.1±4.17U/mg protein), 
(29.43±1.38U/mg protein) and (30.60±2.05ug/ml) respectively when compared to the BPH group 
(35.5±0.97U/mg protein), (11.36±2.39U/mg protein) and (15.60±1.14ug/ml). Antioxidant, PSA 
and relative prostate weight results may be due to the phytochemicals present in the plant. These 
findings also indicate that Laportea aestuans could be useful in the management of benign 
prostatic hyperplasia. 
Key words: Laportea aestuans, benign prostatic hyperplasia, prostate specific antigen, 
antioxidant, phytochemicals.  
